Pathological Complete Response: Clinical Trials

1 trial for Pathological Complete Response, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Pathological Complete Response: new trials by email Literature Review of Pathological Complete Response trials Research Report on Pathological Complete Response

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Immunochemotherapy and Chemoradiotherapy Followed by Surgery for Advanced Esophageal Squamous Cell Carcinoma
Tislelizumab, Paclitaxel, Cisplatin - ESCC, Total Neoadjuvant Treatment
Phase 2RecruitingNational Taiwan University Hospital502025-07-232026-01-27

Interventions

Chemoradiotherapy (1)  ·  Cisplatin (1)  ·  Paclitaxel (1)  ·  tislelizumab (1)

Sponsors

National Taiwan University Hospital (1)

Countries

Taiwan (1)